Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
activated umbilical cord blood T cells
- Development stage
- Unknown
- Lead developer
- Affiliated Hospital of Inner Mongolia Medical University
- Modality
- Cell Therapies
- Administration
- Intravenous
01
Overview
Activated umbilical cord blood T cells is an experimental adoptive cell-based immunotherapy being investigated by the First Teaching Hospital of Inner Mongolia Medical University. The therapy involves the ex vivo activation and expansion of T cells derived from umbilical cord blood mononuclear cells (UCBMCs). Unlike traditional autologous T cell therapies, this approach utilizes allogeneic T cells from cord blood, which are characterized by a more naive phenotype and potentially lower risk of graft-versus-host disease. The activated cells are administered to patients to enhance the immune system's ability to recognize and eliminate cancer cells. It is currently being studied in clinical trials for the treatment of solid tumors, including small cell lung cancer, renal cell carcinoma, and primary liver cancer.
- Other names
- activated UCB T cellsumbilical cord blood-derived T cells
Beyond the preview
Go deeper on activated umbilical cord blood T cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on activated umbilical cord blood T cells.